Global Testosterone Transdermal System Market Growth 2025-2031

Publication ID:

LPI03258214

Publication Date:

March 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Testosterone Transdermal System market size is predicted to grow from US$ 165 million in 2025 to US$ 239 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Testosterone Transdermal is a testosterone replacement that acts like the natural sex hormone.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淭estosterone Transdermal System Industry Forecast鈥� looks at past sales and reviews total world Testosterone Transdermal System sales in 2024, providing a comprehensive analysis by region and market sector of projected Testosterone Transdermal System sales for 2025 through 2031. With Testosterone Transdermal System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Transdermal System industry.
This Insight Report provides a comprehensive analysis of the global Testosterone Transdermal System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Transdermal System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Testosterone Transdermal System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Transdermal System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Transdermal System.
This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Transdermal System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Testosterone Patches
Testosterone Gels
Segmentation by Application:
Online Sales
Drugstore Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Allergan(Actavis)
AbbVie
Endo International
Aytu BioPharma
Upsher-Smith Laboratories
Kyowa Hakko Kirin Co., Ltd.
Besins Healthcare
Perrigo
TWi Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Testosterone Transdermal System market?
What factors are driving Testosterone Transdermal System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Transdermal System market opportunities vary by end market size?
How does Testosterone Transdermal System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Testosterone Transdermal System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Testosterone Transdermal System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Testosterone Transdermal System by Country/Region, 2020, 2024 & 2031
2.2 Testosterone Transdermal System Segment by Type
2.2.1 Testosterone Patches
2.2.2 Testosterone Gels
2.3 Testosterone Transdermal System Sales by Type
2.3.1 Global Testosterone Transdermal System Sales Market Share by Type (2020-2025)
2.3.2 Global Testosterone Transdermal System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Testosterone Transdermal System Sale Price by Type (2020-2025)
2.4 Testosterone Transdermal System Segment by Application
2.4.1 Online Sales
2.4.2 Drugstore Sales
2.5 Testosterone Transdermal System Sales by Application
2.5.1 Global Testosterone Transdermal System Sale Market Share by Application (2020-2025)
2.5.2 Global Testosterone Transdermal System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Testosterone Transdermal System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Testosterone Transdermal System Breakdown Data by Company
3.1.1 Global Testosterone Transdermal System Annual Sales by Company (2020-2025)
3.1.2 Global Testosterone Transdermal System Sales Market Share by Company (2020-2025)
3.2 Global Testosterone Transdermal System Annual Revenue by Company (2020-2025)
3.2.1 Global Testosterone Transdermal System Revenue by Company (2020-2025)
3.2.2 Global Testosterone Transdermal System Revenue Market Share by Company (2020-2025)
3.3 Global Testosterone Transdermal System Sale Price by Company
3.4 Key Manufacturers Testosterone Transdermal System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Transdermal System Product Location Distribution
3.4.2 Players Testosterone Transdermal System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Testosterone Transdermal System by Geographic Region
4.1 World Historic Testosterone Transdermal System Market Size by Geographic Region (2020-2025)
4.1.1 Global Testosterone Transdermal System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Testosterone Transdermal System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Testosterone Transdermal System Market Size by Country/Region (2020-2025)
4.2.1 Global Testosterone Transdermal System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Testosterone Transdermal System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Testosterone Transdermal System Sales Growth
4.4 APAC Testosterone Transdermal System Sales Growth
4.5 Europe Testosterone Transdermal System Sales Growth
4.6 Middle East & Africa Testosterone Transdermal System Sales Growth
5 Americas
5.1 Americas Testosterone Transdermal System Sales by Country
5.1.1 Americas Testosterone Transdermal System Sales by Country (2020-2025)
5.1.2 Americas Testosterone Transdermal System Revenue by Country (2020-2025)
5.2 Americas Testosterone Transdermal System Sales by Type (2020-2025)
5.3 Americas Testosterone Transdermal System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Transdermal System Sales by Region
6.1.1 APAC Testosterone Transdermal System Sales by Region (2020-2025)
6.1.2 APAC Testosterone Transdermal System Revenue by Region (2020-2025)
6.2 APAC Testosterone Transdermal System Sales by Type (2020-2025)
6.3 APAC Testosterone Transdermal System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Testosterone Transdermal System by Country
7.1.1 Europe Testosterone Transdermal System Sales by Country (2020-2025)
7.1.2 Europe Testosterone Transdermal System Revenue by Country (2020-2025)
7.2 Europe Testosterone Transdermal System Sales by Type (2020-2025)
7.3 Europe Testosterone Transdermal System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Testosterone Transdermal System by Country
8.1.1 Middle East & Africa Testosterone Transdermal System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Testosterone Transdermal System Revenue by Country (2020-2025)
8.2 Middle East & Africa Testosterone Transdermal System Sales by Type (2020-2025)
8.3 Middle East & Africa Testosterone Transdermal System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Transdermal System
10.3 Manufacturing Process Analysis of Testosterone Transdermal System
10.4 Industry Chain Structure of Testosterone Transdermal System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Transdermal System Distributors
11.3 Testosterone Transdermal System Customer
12 World Forecast Review for Testosterone Transdermal System by Geographic Region
12.1 Global Testosterone Transdermal System Market Size Forecast by Region
12.1.1 Global Testosterone Transdermal System Forecast by Region (2026-2031)
12.1.2 Global Testosterone Transdermal System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Testosterone Transdermal System Forecast by Type (2026-2031)
12.7 Global Testosterone Transdermal System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Allergan(Actavis)
13.1.1 Allergan(Actavis) Company Information
13.1.2 Allergan(Actavis) Testosterone Transdermal System Product Portfolios and Specifications
13.1.3 Allergan(Actavis) Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan(Actavis) Main Business Overview
13.1.5 Allergan(Actavis) Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Testosterone Transdermal System Product Portfolios and Specifications
13.2.3 AbbVie Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Testosterone Transdermal System Product Portfolios and Specifications
13.3.3 Endo International Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Aytu BioPharma
13.4.1 Aytu BioPharma Company Information
13.4.2 Aytu BioPharma Testosterone Transdermal System Product Portfolios and Specifications
13.4.3 Aytu BioPharma Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Aytu BioPharma Main Business Overview
13.4.5 Aytu BioPharma Latest Developments
13.5 Upsher-Smith Laboratories
13.5.1 Upsher-Smith Laboratories Company Information
13.5.2 Upsher-Smith Laboratories Testosterone Transdermal System Product Portfolios and Specifications
13.5.3 Upsher-Smith Laboratories Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Upsher-Smith Laboratories Main Business Overview
13.5.5 Upsher-Smith Laboratories Latest Developments
13.6 Kyowa Hakko Kirin Co., Ltd.
13.6.1 Kyowa Hakko Kirin Co., Ltd. Company Information
13.6.2 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Product Portfolios and Specifications
13.6.3 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kyowa Hakko Kirin Co., Ltd. Main Business Overview
13.6.5 Kyowa Hakko Kirin Co., Ltd. Latest Developments
13.7 Besins Healthcare
13.7.1 Besins Healthcare Company Information
13.7.2 Besins Healthcare Testosterone Transdermal System Product Portfolios and Specifications
13.7.3 Besins Healthcare Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Besins Healthcare Main Business Overview
13.7.5 Besins Healthcare Latest Developments
13.8 Perrigo
13.8.1 Perrigo Company Information
13.8.2 Perrigo Testosterone Transdermal System Product Portfolios and Specifications
13.8.3 Perrigo Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Perrigo Main Business Overview
13.8.5 Perrigo Latest Developments
13.9 TWi Pharmaceuticals
13.9.1 TWi Pharmaceuticals Company Information
13.9.2 TWi Pharmaceuticals Testosterone Transdermal System Product Portfolios and Specifications
13.9.3 TWi Pharmaceuticals Testosterone Transdermal System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 TWi Pharmaceuticals Main Business Overview
13.9.5 TWi Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂